|
|
A Toll/IL-1R/resistance domain-containing thioredoxin regulates phagocytosis in Entamoeba histolytica
|
|
|
|
|
نویسنده
|
mancilla-herrera i. ,méndez-tenorio a. ,wong-baeza i. ,jiménez-uribe a.p. ,alcántara-hernández m. ,ocadiz-ruiz r. ,moreno-eutimio m.a. ,arriaga-pizano l.a. ,lápez-macías c. ,gonzález-y-merchand j. ,isibasi a.
|
منبع
|
parasites and vectors - 2012 - دوره : 5 - شماره : 1
|
چکیده
|
Background: entamoeba histolytica is a protozoan parasite that infects humans and causes amebiasis affecting developing countries. phagocytosis of epithelial cells,erythrocytes,leucocytes,and commensal microbiota bacteria is a major pathogenic mechanism used by this parasite. a toll/il-1r/resistance (tir) domain-containing protein is required in phagocytosis in the social ameba dictyostelium discoideum,an ameba closely related to entamoeba histolytica in phylogeny. in insects and vertebrates,tir domain-containing proteins regulate phagocytic and cell activation. therefore,we investigated whether e. histolytica expresses tir domain-containing molecules that may be involved in the phagocytosis of erythrocytes and bacteria. methods. using in silico analysis we explored in entamoeba histolytica databases for tir domain containing sequences. after silencing tir domain containing sequences in trophozoites by sirna we evaluated phagocytosis of erythrocytes and bacteria. results: we identified an e. histolytica thioredoxin containing a tir-like domain. the secondary and tertiary structure of this sequence exhibited structural similarity to tir domain family. thioredoxin transcripts silenced in e. histolytica trophozoites decreased erythrocytes and e. coli phagocytosis. conclusion: tir domain-containing thioredoxin of e. histolytica could be an important element in erythrocytes and bacteria phagocytosis. © 2012 mancilla-herrera et al.; licensee biomed central ltd.
|
کلیدواژه
|
Bacteria phagocytosis; Entamoeba histolytica phagocytosis; Erythrocytes phagocytosis; Toll/IL-1R/resistance domain
|
آدرس
|
medical research unit on immunochemistry,specialties hospital,mexican social security institute (imss),mexico city,mexico,graduate program on biomedicine and biotechnology,encb-ipn,mexico city, Mexico, biochemistry department,national school of biological sciences,national polytechnic institute (encb-ipn),mexico city, Mexico, medical research unit on immunochemistry,specialties hospital,mexican social security institute (imss),mexico city,mexico,graduate program on immunology,encb-ipn,mexico city, Mexico, medical research unit on immunochemistry,specialties hospital,mexican social security institute (imss),mexico city, Mexico, medical research unit on immunochemistry,specialties hospital,mexican social security institute (imss),mexico city,mexico,graduate program on immunology,encb-ipn,mexico city, Mexico, departamento de infectámica y patogénesis molecular,centro de investigacián y de estudios avanzados del ipn,méxico city, Mexico, medical research unit on immunochemistry,specialties hospital,mexican social security institute (imss),mexico city,mexico,mexicos juarez hospital,ssa,mexico city, Mexico, medical research unit on immunochemistry,specialties hospital,mexican social security institute (imss),mexico city, Mexico, medical research unit on immunochemistry,specialties hospital,mexican social security institute (imss),mexico city, Mexico, molecular microbiology laboratory,microbiology department,encb-ipn,mexico city, Mexico, medical research unit on immunochemistry,specialties hospital,mexican social security institute (imss),mexico city, Mexico
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|